{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T07:45:41Z","timestamp":1696578341496},"reference-count":48,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2016,8,21]],"date-time":"2016-08-21T00:00:00Z","timestamp":1471737600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"National Institute for Communicable Diseases"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>There are limited molecular epidemiological studies of hepatitis C at a national level in South Africa. The introduction of newer treatment modalities for hepatitis C requires knowledge of the genotypes as these may have different prognostic and therapeutic implications. This retrospective study describes genotype distributions of patients attending specialist clinics and a blood donor group studied during the period 2008\u20132012 in South Africa. Residual samples from diagnostic viral load testing from specialist clinics in South Africa (n=941) and from the South African National Blood Service (n=294) were analysed quantitatively by real\u2010time <jats:styled-content style=\"fixed-case\">PCR<\/jats:styled-content> and genotyped using the Versant line probe assay or sequencing. Genotype 1 was predominant in blood donors (34%), whilst genotype 5a was prevalent in patients (36%). In the blood donor group, genotype 4 was detected for the first time. Genotype 2 was rare in the patient group and not detected in blood donors. Genotype 1 was the predominant genotype in the younger age groups (less than 30\u00a0years), whereas genotype 5a was found at higher proportions in the older age groups for both the patient and blood donor groups, comprising more than 60% of genotypes in those older than 50\u00a0years. Genotypes 1 and 5 were at highest proportions across all provinces compared to other genotypes. In blood donors, genotype 1 was predominant among Caucasians (43%) and genotype 5a among Blacks (54%). Such information is required for planning the impact on the health sector with regard to newly emerging therapies for hepatitis C and burden of disease.<\/jats:p>","DOI":"10.1111\/jvh.12571","type":"journal-article","created":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T04:46:43Z","timestamp":1471841203000},"page":"881-888","source":"Crossref","is-referenced-by-count":9,"title":["Hepatitis C genotype distribution in patient and blood donor samples in South Africa for the period 2008\u20132012"],"prefix":"10.1111","volume":"23","author":[{"given":"N.","family":"Prabdial\u2010Sing","sequence":"first","affiliation":[{"name":"Centre for Vaccines and Immunology National Institute for Communicable Diseases (NICD)  Johannesburg South Africa"},{"name":"Faculty of Health Sciences Division of Virology and Communicable Diseases Surveillance School of Pathology University of the Witwatersrand  Johannesburg South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Chirwa","sequence":"additional","affiliation":[{"name":"Division of Epidemiology and Biostatistics School of Public Health University of the Witwatersrand  Johannesburg South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Thaver","sequence":"additional","affiliation":[{"name":"Centre for Vaccines and Immunology National Institute for Communicable Diseases (NICD)  Johannesburg South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Smuts","sequence":"additional","affiliation":[{"name":"Division of Medical Virology University of Cape Town and National Health Laboratory Services  Cape Town South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Vermeulen","sequence":"additional","affiliation":[{"name":"Donation Testing South African National Blood Service  Roodepoort South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Suchard","sequence":"additional","affiliation":[{"name":"Centre for Vaccines and Immunology National Institute for Communicable Diseases (NICD)  Johannesburg South Africa"},{"name":"Molecular Medicine and Haematology School of Pathology Faculty of Health Sciences University of the Witwatersrand  Johannesburg South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. J.","family":"Puren","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences Division of Virology and Communicable Diseases Surveillance School of Pathology University of the Witwatersrand  Johannesburg South Africa"},{"name":"Centre for HIV and STI National Institute for Communicable Diseases (NICD)  Johannesburg South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,8,21]]},"reference":[{"key":"e_1_2_6_2_1","unstructured":"WHO.World Health Organisation. Global Alert and Response inWHO\/CDS\/CSR\/LYO\/2003.2003;1\u201350."},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01934.x"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofu065"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.2003.00311.x"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21262"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26744"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-75-5-1053"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)00376-9"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.09.009"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12493"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890420414"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-78-6-1341"},{"key":"e_1_2_6_14_1","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1128\/jcm.33.6.1679-1681.1995","article-title":"Genotyping of hepatitis C virus in South Africa","volume":"33","author":"Smuts HE","year":"1995","journal-title":"J Clin Microbiol"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-008-0227-2"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhin.2001.1143"},{"key":"e_1_2_6_17_1","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1128\/jcm.34.11.2815-2818.1996","article-title":"Identification of numerous hepatitis C virus genotypes in Montreal, Canada","volume":"34","author":"Bernier L","year":"1996","journal-title":"J Clin Microbiol"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.04695.x"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.7.2645-2647.2002"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.7.3030-3035.2004"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.80.9.4220-4226.2006"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e3182a1789c"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-014-2220-2"},{"key":"e_1_2_6_24_1","first-page":"20","article-title":"South African hepatitis C management guideline","volume":"8","author":"Botha J","year":"2010","journal-title":"S Afr Gastroenterol Rev"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12371"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214853"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60247-0"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-73-5-1131"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/msm092"},{"key":"e_1_2_6_30_1","unstructured":"STATA Corp.STATA statistical software release 13.2013 College Station Texas USA."},{"key":"e_1_2_6_31_1","first-page":"789","article-title":"Unsafe injections in the developing world and transmission of bloodborne pathogens: a review","volume":"77","author":"Simonsen L","year":"1999","journal-title":"Bull World Health Organ"},{"key":"e_1_2_6_32_1","first-page":"603","article-title":"Hepatitis C virus infection rate in volunteer blood donors from the Western Cape\u2013comparison of screening tests and PCR","volume":"87","author":"Tucker TJ","year":"1997","journal-title":"S Afr Med J"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02110.x"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2013.10.022"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02220-07"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s150100050005"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1017\/S095026880800054X"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.13.2.223-235.2000"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1586\/eri.11.94"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.1237"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2012.09.017"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.3343\/alm.2012.32.3.210"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27259"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290122"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.36993"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1086\/426515"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2008.05649.x"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2011.01481.x"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.2135"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvh.12571","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvh.12571","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvh.12571","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T18:39:12Z","timestamp":1696531152000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jvh.12571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,21]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["10.1111\/jvh.12571"],"URL":"https:\/\/doi.org\/10.1111\/jvh.12571","archive":["Portico"],"relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,21]]}}}